Increased Epidermal Growth Factor–Like Ligands Are Associated With Elevated Vascular Nicotinamide Adenine Dinucleotide Phosphate Oxidase in a Primate Model of Atherosclerosis
- 1 October 2012
- journal article
- research article
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 32 (10) , 2452-2460
Abstract
Objective—: To characterize the relationship between the expression of epidermal growth factor (EGF)-like ligands and vascular nicotinamide adenine dinucleotide phosphate (NADPH) oxidase expression and activity in a primate model of atherosclerosis. Methods and Results—: Adult male Cynomolgus monkeys were fed a normal or atherogenic (AS) diet for 45 months, after which animals from the AS group were placed on a normal diet for 8 months (regression). The expression of membrane-associated EGF-like ligands was increased in arteries from animals on the AS diet and normalized in the regression group. EGF-like ligands were distributed throughout atherosclerotic vessels but predominantly colocalized with macrophages. Consistent with ligand shedding, circulating heparin-bound EGF was elevated in the plasma of AS monkeys but not in those on regression diet. Atherosclerosis was associated with the activation of EGF receptor signaling. Expression of NADPH oxidase subunits Nox1 and Nox2 but not Nox4 or Nox5 was increased in arteries from monkeys on the AS diet and returned to normal with regression. Levels of Nox1 and Nox2 positively correlated with EGF-like ligands. In cultured monkey smooth muscle cells, treatment with EGF-like ligands increased Nox1 expression and activity. Conclusion—: These data identify EGF-like ligands as potential modulators of atherogenesis, resulting in part from increased vascular NADPH oxidase activity.Keywords
This publication has 55 references indexed in Scilit:
- Glutathione peroxidase-deficient smooth muscle cells cause paracrine activation of normal smooth muscle cells via cyclophilin AVascular Pharmacology, 2011
- Role for Nox1 NADPH oxidase in atherosclerosisAtherosclerosis, 2011
- Plasma Kallikrein Promotes Epidermal Growth Factor Receptor Transactivation and Signaling in Vascular Smooth Muscle through Direct Activation of Protease-activated ReceptorsJournal of Biological Chemistry, 2010
- NADPH Oxidase NOX1 Controls Autocrine Growth of Liver Tumor Cells through Up-regulation of the Epidermal Growth Factor Receptor PathwayJournal of Biological Chemistry, 2010
- NADPH Oxidases: Functions and Pathologies in the VasculatureArteriosclerosis, Thrombosis, and Vascular Biology, 2010
- A Differential Role for Endocytosis in Receptor-Mediated Activation of Nox1Antioxidants & Redox Signaling, 2010
- Mechanisms of Vascular Smooth Muscle NADPH Oxidase 1 (Nox1) Contribution to Injury-Induced Neointimal FormationArteriosclerosis, Thrombosis, and Vascular Biology, 2009
- Calcium-Dependent NOX5 Nicotinamide Adenine Dinucleotide Phosphate Oxidase Contributes to Vascular Oxidative Stress in Human Coronary Artery DiseaseJACC, 2008
- Nox5 mediates PDGF-induced proliferation in human aortic smooth muscle cellsFree Radical Biology and Medicine, 2008
- The pathogenesis of atherosclerosis: a perspective for the 1990sNature, 1993